Blog

featured image of FDA Fast Tracks TME Pharma's Glioblastoma Treatment

FDA Fast Tracks TME Pharma’s Glioblastoma Treatment

BIOT

💊 TME Pharma's NOX-A12 gets FDA Fast Track for glioblastoma, aiming to expedite the review and approval process. 🎯

featured image of Forbion Joins Oversubscribed US Financing Rounds

Forbion Joins Oversubscribed US Financing Rounds

BIOT

🇪🇺🚀 European VC firm Forbion joins oversubscribed US financing rounds for Capstan Therapeutics and Engrail Therapeutics 🌍💰 LifeSciences

featured image of Germany's Bold Move to Boost Clinical Trials

Germany’s Bold Move to Boost Clinical Trials

BIOT

📢 Germany's draft Medical Research Act aims to speed up clinical trials by removing obstacles and streamlining authorization procedures. However, industry stakeholders are disappointed.

featured image of Revolutionary Biofuel Breakthrough: $6M Funding Fuels Terragia's Low-Carbon Tech

Revolutionary Biofuel Breakthrough: $6M Funding Fuels Terragia’s Low-Carbon Tech

BIOT

Terragia Biofuel raises $6 million to develop low-carbon biofuel technology 🌍🔬💰🌱🚀👥

featured image of Lonza Revolutionizes Respiratory Treatment with Advanced Pulmonary Delivery Services

Lonza Revolutionizes Respiratory Treatment with Advanced Pulmonary Delivery Services

BIOT

📢 Lonza expands service offering for spray-dried biologics for pulmonary delivery, improving respiratory therapies and patient access. 🌬️💊🌍💪

featured image of Revolutionary Monoclonal Antibodies: Unleashing Advanced Therapies

Revolutionary Monoclonal Antibodies: Unleashing Advanced Therapies

BIOT

🔍 Monoclonal antibodies (mAbs) have paved the way for advanced therapies, thanks to decades of development and manufacturing improvements. 💪

featured image of FDA Releases Game-Changing CAR-T Guidelines: Everything You Need to Know!

FDA Releases Game-Changing CAR-T Guidelines: Everything You Need to Know!

BIOT

📢 The FDA published new guidance for CAR-T cell products, covering change management, risk assessment, flow cytometry, and more. 👩‍🔬🔬🧪🗂 CAR-T FDA

featured image of Revolutionary 10-Day Lentiviral Vector Breakthrough Boosts Gene Therapy Efficiency

Revolutionary 10-Day Lentiviral Vector Breakthrough Boosts Gene Therapy Efficiency

BIOT

🔍 Researchers have developed a method to optimize lentiviral vector production, allowing for high-titer LV harvest for more than 10 days. 💉💥🧬

featured image of Robots and AI Revolutionize Cell and Gene Therapy Manufacturing!

Robots and AI Revolutionize Cell and Gene Therapy Manufacturing!

BIOT

🤖🔬 Researchers suggest that robots and AI can address manufacturing challenges in cell and gene therapy. ⬆️🌍 The industry is growing rapidly, requiring skilled personnel and increased production. 🤖🔬 Automation and AI can improve efficiency and reduce costs.

featured image of Gut Bacteria: The Hidden Culprits Behind Autoimmune Kidney Diseases?

Gut Bacteria: The Hidden Culprits Behind Autoimmune Kidney Diseases?

BIOT

📢 New study reveals how gut bacteria may trigger autoimmune diseases in kidneys by leaking antigens, activating immune system. 🦠💉